Identified a new lead compound for anticancer therapy
Research of Prof. R. Žalubovskis group (LIOS) and scientists from Serbia (Institute for Biological Research “Sinisa Stankovic”; Institute of Nuclear Sciences VINCA ) and Russia
30/10/2019